India Calls for Global Cooperation to Combat Antimicrobial Resistance

Addressing the gathering, the minister stressed on the critical threat AMR poses to global public health, undermining decades of progress in modern medicine. She called for the integration of AMR containment strategies into various health programs, including pandemic preparedness, health system strengthening, and universal health coverage.

Revised Operational Guidelines and Training Manual of Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease (NAFLD) is becoming a major public health concern in India, with a prevalence ranging from 9% to 32%. The revised guidelines focus on health promotion, early detection, and a multidisciplinary approach to NAFLD care. The training module equips healthcare professionals with the knowledge and skills to identify, manage, and prevent NAFLD, particularly at the primary level.

Inclusion of Acupuncture Professionals As ‘Other Care Professionals’

The Central Government has amended the Schedule to the National Commission for Allied and Healthcare Professions Act, 2021 to include Acupuncture Professionals as a recognized category of other care providers. The amendment was made after consultation with the National Commission for Allied and Healthcare Professions.

CDSCO Requires Registration Of Clinical Research Organizations

The Central Drugs Standard Control Organization (CDSCO) has announced amendments to the New Drugs and Clinical Trials Rules, 2019. These amendments aim to strengthen the regulatory framework for clinical research organizations (CROs) in India. CROs are now required to register with the Central Licensing Authority before conducting clinical trials.

CDSCO Publishes Not Of Standard Quality And Spurious Alert For August 2024

The NSQ drug list specifies a total of 11 drugs that were detected to be deficient by State Lab Drugs Control Laboratory, Telangana. All of these 11 drugs were declared to be not of standard quality. The NSQ drug list for central CDSCO laboratories specifies a total of 48 drugs that were detected to be deficient. Additionally, CDSCO has also identified 5 drugs to be spurious.